Rusty Williams | President and CEO |
Helen Collins | SVP and CMO |
Aron Knickerbocker | COO |
Marc Belsky | SVP and CFO |
Derek Cole | Investor Relations Advisory Solutions |
Michael Schmidt | Leerink |
Kennen MacKay | RBC Capital Markets |
Jim Birchenough | Wells Fargo Securities |
Ian Somaiya | BMO Capital |
Eun Yang | Jefferies |
Christopher Marai | Nomura Instinet |
Tony Butler | Guggenheim Securities |
Good day, ladies and gentlemen and welcome to the Third Quarter 2017 Earnings Call for Five Prime Therapeutics.
As a reminder, this conference call maybe recorded. I'd now like to introduce your host for today's conference call, Mr. Derek Cole.
You may begin.